info@biomedres.us   +1 (720) 414-3554
  One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA

Biomedical Journal of Scientific & Technical Research

August, 2020, Volume 29, 5, pp 22746-22748

Case Report

Case Report

Eruptive Pseudoangiomatosis in Adult Associated to Parvovirus B19

Soriano Maldonado Cristina1* and López de San Vicente Hernández Iranzu2

Author Affiliations

1Primary care physician, Primary Care Center of Muchamiel, San Juan de Alicante Department, Alicante, Spain

2Primary care physician, Primary Care Center of San Adrian, Bilbao, Spain

Received: August 15, 2020 | Published: August 25, 2020

Corresponding author: Cristina Soriano Maldonado, Primary Care Center of Muchamiel, Calle del Mar, 0, 03110, Muchamiel (Alicante), Spain

DOI: 10.26717/BJSTR.2020.29.004850

Abstract

Eruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema. It consists of the acute onset of small erythematous papules, similar to angiomas that disappear spontaneously. The etiology is still unknown, and it occurs commonly in children, but it has also been described in adults.

Summary

It presents a clinical case of a 56-year-old female, attended at the Primary Care Center in Muchamiel, Spain, with acute onset of pruritic erythematous papules lesions. Serological test showed parvovirus B19 acute infection and the biopsy confirms the diagnosis.

Keywords: Eruptive Pseudoangiomatosis; Parvovirus B19; Adults

Introduction

Eruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema of an unknown etiology. It consists of an acute onset of small eruption of distinctive erythematous angioma-like papules that are often surrounded by a pale halo [1-3]. Histologic findings show dilated dermal blood vessels with plump endothelial cells protruding into the lumen and mild-to moderate perivascular lymphohistiocytic infiltrates [4]. The etiology of this eruptive disease is still unknown. However, association with insect bites [5] and with ECHO virus, coxsackie B, Epstein-Barr virus and cytomegalovirus [6,7] have been described. We are reporting a case of a woman with this condition associated to parvovirus B19.

Case Report

A 56-year-old female patient visited our Primary Care center in July 2020. The current condition begins 24 hours prior to consult, with a generalized onset of 3-4mm erythematous papules with a peripheral pale halo. Lesions were moderate pruritic, and they were located on her upper and lower extremities and trunk mostly (Figure 1) No systemic symptoms, including fever, were present. She had no history of upper respiratory tract infection and no medical problems. We took a skin biopsy and histopathological findings showed a mild superficial perivascular dermatitis. Laboratory findings revealed an acute Parvovirus B19 (IgM+). No other blood test findings were remarkable. Treatment was started with cetirizine 10mg per day and the lesions spontaneously disappeared after approximately 3 weeks.

Figure 1:

A. Well-defined red papules with a perilesional blanched halo on the back and

B. on the lower extremities.

Discussion

EP usually presents as an erythematous papules with a perilesional pale halo that disappears in a few days. This illness is unusual and the exanthem eruption is usually asymptomatic or slightly pruritic [2,8]. The first time that this disease was described was in 1969 by Cherry et al in children with enterovirus-enteric cytopathic human orphan (ECHO) virus infection [1] and Navarro, et al. [6] described a case report with clinical evidence of Epstein- Barr virus (EBV) In 1993, as well as, Prose et al described an eruption with similar features in 3 children, but unfortunately could not confirm its origin [2]. It is usually overserved in childhood [2,8], but in 2000, 10 cases were reported in Spanish adults, most of them in women [6,8]. In 2016, another case of a 73-year-old female was reported in Spain [9]. Recently, in 2018, 12 cases in adults were described from India by Chopra, et al. [10], who observed that females are more commonly affected. Our case report appears in summer, the same as the 7 cases described by Barrio, et al. [11]. The patient had no history of preceding symptoms. The onset of dermic lesions was 24 hours before consulting, which started from the extremities and spread to involve the trunk. The eruption was moderately pruritic. Multiple eruptive capillary hemangioma, viral exanthema, multiple pyogenic granuloma, popular urticaria or insect bites were considered in the differential diagnosis.

Histological findings show that epidermis is generally unaffected and there is no evidence of vascular proliferation; these findings justify the name of this disease: “eruptive pseudoangiomatosis” [2]. As we see in our patient, the clinical features and histological findings were similar to those described for EP. Its etiology is still unclear, however, most cases in the literature were related to viruses [6,12,13] but the development of the disease has also been observed due to insect bites5 and also in 2 subjects after taking an herbal medicine [13]. In our case report, we could perform a serology test and acute Parvovirus B19 infection was detected, which is first described in literature. Usually the family Parvoviridae doesn’t affect humans, however, the only one that can be pathogenic in people is Parvovirus B19. On the one hand, immunocompetent individuals’ immune system can control the infection, causing the erythema infectiosum (in children) and polyarthropathy (in adults). However, a pure red cell aplasia and chronic anemia can be caused in immunocompromised individuals [14]. Nevertheless, it has never been related to EP or to the onset of angioma-like lesions. There’s no specific treatment for EP, however, oral antihistamines and topical steroids can decrease syntoms [10]. As in our patient who received oral antihistamines.

Conclusion

This is the first case described in literature where the Parvovirus B19 is detected as the main cause of eruptive pseudoangiomatosis in adults. Because of that, it is necessary to keep in mind that many types of virus infection could cause this disease and we need to look for them conscientiously through laboratory and serological tests. Our report highlights the importance of keeping on studying the etiology of this disease in order to detect silent diseases, so that, we suggest that more cases need to be studied.

Funding Source

No external funding for this manuscript.

Financial Disclosure

The authors have no financial relationships relevant to this article to disclose.

Conflict of Interest

The authors have declared no conflict of interest.

References

Case Report

Eruptive Pseudoangiomatosis in Adult Associated to Parvovirus B19

Soriano Maldonado Cristina1* and López de San Vicente Hernández Iranzu2

Author Affiliations

1Primary care physician, Primary Care Center of Muchamiel, San Juan de Alicante Department, Alicante, Spain

2Primary care physician, Primary Care Center of San Adrian, Bilbao, Spain

Received: August 15, 2020 | Published: August 25, 2020

Corresponding author: Cristina Soriano Maldonado, Primary Care Center of Muchamiel, Calle del Mar, 0, 03110, Muchamiel (Alicante), Spain

DOI: 10.26717/BJSTR.2020.29.004850

Abstract

Eruptive pseudoangiomatosis (EP) is a rare disease characterized by benign spontaneous regressing exanthema. It consists of the acute onset of small erythematous papules, similar to angiomas that disappear spontaneously. The etiology is still unknown, and it occurs commonly in children, but it has also been described in adults.

Summary

It presents a clinical case of a 56-year-old female, attended at the Primary Care Center in Muchamiel, Spain, with acute onset of pruritic erythematous papules lesions. Serological test showed parvovirus B19 acute infection and the biopsy confirms the diagnosis.

Keywords: Eruptive Pseudoangiomatosis; Parvovirus B19; Adults